commencing on July 1, 2024 and thereafter. Additionally, the Credit Facility Amendment requires the Company to have received gross proceeds from the issuance of additional shares of the Company’s Series B Preferred Stock in an amount no less than (i) $6,500,000 on or prior to January 31, 2023, (ii) $3,500,000 on or prior to March 31, 2023, and (iii) $3,500,000 on or prior to June 30, 2023. In compliance with this Credit Facility covenant, the Company issued 650,000 additional shares of Series B Preferred Stock for total proceeds of $6,500,000 in January 2023, 350,000 additional shares of Series B Preferred Stock for total proceeds of $3,500,000 in March 2023, and 350,000 additional shares of Series B Preferred Stock for total proceeds of $3,500,000 in June 2023. See Note 13 – Stockholders’ Equity to the accompanying consolidated financial statements for additional details regarding issuances of Series B Preferred Stock.
These financial and restrictive covenants may limit the investments the Company may make and the Company’s ability to make dividends and distributions. As of December 31, 2023, the Company is in compliance with all financial and restrictive covenants under the Credit Facility Amendment. The occurrence of an event of default under the Credit Facility Amendment could result in the termination of the commitments thereunder and in all loans and other obligations becoming immediately due and payable.
In June 2023, we, through certain of our subsidiaries, entered into a non-recourse real estate revolving loan promissory note (as amended, the “Note Payable Facility”) with HP Holdings Company, LLC (“HP HoldCo”), an entity affiliated with Hale Partnership Capital Management, LLC (“HPCM”), which was founded by our Chairman and Chief Executive Officer, Steven A. Hale II, and HCM Agency, LLC (“HCM Agency”), an entity affiliated with HPCM. In October 2023, we amended the Note Payable Facility to, among other things, increase the total availability under the Note Payable Facility from $2,500,000 to $4,500,000 and added Hale ICFG Fund LP, an entity affiliated with HPCM, as an additional lender to the facility. Borrowings under the Note Payable Facility bear interest based on 3-month term SOFR plus 340 basis points. The Note Payable Facility matures on June 30, 2024.
On August 4, 2023, we, through our Operating Partnership, entered into a bridge loan agreement by and among the Operating Partnership, as borrower, certain of our indirect subsidiaries acting as subsidiary guarantors, the lenders from time to time party thereto and KeyBank National Association, as administrative agent (the “Bridge Loan Agreement”), providing for a Bridge Loan Facility with total availability of up to $25,000,000. The Company has used, and intends to continue to use, the Bridge Loan Facility to repay certain indebtedness, fund acquisitions and capital expenditures and provide working capital. Borrowings under the Bridge Loan Facility bear interest at substantially similar rates as the Amended Credit Facility Interest Rates. The Bridge Loan Facility was set to mature on February 2, 2024; however, the Company, through its Operating Partnership, amended the Bridge Loan Agreement to extend the maturity date of the facility to June 30, 2024.
As of December 31, 2023, we had borrowed approximately $81,000,000, with approximately $19,000,000 committed and undrawn, and approximately $13,000,000 of availability for borrowing under our Credit Facility.
As of December 31, 2023, the Company had total outstanding borrowings on the Note Payable Facility of $4,500,000.
In addition, as of December 31, 2023, we had borrowed approximately $18,000,000, with approximately $7,000,000 committed and undrawn, and approximately $5,100,000 of availability for borrowing under our Bridge Loan Facility.
Estimated Fair Market Value of Equity (“FMV”) Per Share as of June 30, 2023
On January 16, 2024, the Board unanimously approved and established an estimated FMV per share of the Company’s Common Stock of $1.42, based on the Company’s estimated FMV divided by the number of outstanding shares of the Company’s Common Stock on a fully diluted basis as of June 30, 2023, less a 10% discount for the lack of marketability of the Company’s common stock. For additional information, see the Company’s Current Report on Form 1-U filed with the SEC on January 19, 2024.
13